BioLife Solutions, Inc. Purchase Obligation
BioLife Solutions, Inc. (BLFS) had Purchase Obligation of $16.30 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:PurchaseObligation · last filed 2026-08-06
- 2026-06-30: Purchase Obligation $16.30M.
- 2026-03-31: Purchase Obligation $17.30M.
- 2025-12-31: Purchase Obligation $9.80M.
- 2025-09-30: Purchase Obligation $7.40M.
| Period end | Purchase Obligation |
|---|---|
| 2026-06-30 | $16.30M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $17.30M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $9.80M 10-K · filed 2026-02-26 |
| 2025-09-30 | $7.40M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $11.50M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $10.00M 10-Q · filed 2025-05-08 |
| 2024-09-30 | $4.20M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $5.80M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $10.00M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $14.30M 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |